3379-2635 Screening compound: 2-[(2Z)-2-[(furan-2-yl)formamido]-3-(4-methoxyphenyl)prop-2-enamido]-3-phenylpropanoic acid

3379-2635 Screening compound: 2-[(2Z)-2-[(furan-2-yl)formamido]-3-(4-methoxyphenyl)prop-2-enamido]-3-phenylpropanoic acid
3379-2635 Screening compound: 2-[(2Z)-2-[(furan-2-yl)formamido]-3-(4-methoxyphenyl)prop-2-enamido]-3-phenylpropanoic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound 3379-2635
2-[(2Z)-2-[(furan-2-yl)formamido]-3-(4-methoxyphenyl)prop-2-enamido]-3-phenylpropanoic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3379-2635

Molecular Formula

C24H22N2O6 (C24 H22 N2 O6)

Compound Name

2-[(2Z)-2-[(furan-2-yl)formamido]-3-(4-methoxyphenyl)prop-2-enamido]-3-phenylpropanoic acid

IUPAC name

2-[(2Z)-2-[(furan-2-yl)formamido]-3-(4-methoxyphenyl)prop-2-enamido]-3-phenylpropanoic acid

SMILES

COc1ccc(/C=C(/C(NC(Cc2ccccc2)C(O)=O)=O)\NC(c2ccco2)=O)cc1

InChI

InChI=1S/C24H22N2O6/c1-31-18-11-9-17(10-12-18)14-19(25-23(28)21-8-5-13-32-21)22(27)26-20(24(29)30)15-16-6-3-2-4-7-16/h2-14,20H,15H2,1H3,(H,25,28)(H,26,27)(H,29,30)/t20-/m0/s1

InChI Key

IFUBMOYZFKIIIE-FQEVSTJZSA-N

MDL Number (MFCD)

MFCD02227547

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

434.45

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.906

Distribution Coefficient, logD

-1.433

Water Solubility, LogSw

-2.34

Polar Surface Area

90.737

Acid Dissociation Constant (pKa)

4.06

Base Dissociation Constant (pKb)

-2.25

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

12.50

3379-2635 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Dark Chemical Matter Library (18430 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Pool
Mechanism of action:
  • Epigenetic
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with 3379-2635 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3379-2635?
Check Price and Availability of 3379-2635, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3379-2635 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3379-2635
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3379-2635
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3379-2635 available by request